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OhJe Lives. The purpose of this study was to determine the
frequency of myocardial ischemia as a potential mechanism for
cardiac arm. t and syncope In young patients with hypertrophic
c - thy who experle
such complications.
ie
r und, Sudden cardiac death and syncope occur fre-
quendy in patients with hyp ertrophic cardlomyopatlay . Although
ventricular arrhythanias account for most of these events in adult
patients, the mechanism
responsible
for cardiac arrest and syn-
cope in young patients has not been established.
Me". Twenty-three patients with hypertrophlc cardiomy-
opaathy, aged 6 to 23 years, with previous cardiac arrest (n W 8),
syncope (a = 7) or a family history of sudden cardiac death (n
8) were evaluated to determine the prevalence of spontaneous
ambulatory ventricular tachycardia (24® to 72-h electrocardio-
graphic (ECG) monitoring), exercise-induced myocardial isch-
emia (thallium scintigraphy) and inducibility of ventricular tachy-
(el physiologic studies) .
Results. Three of IS patients with a history of cardiac arrest or
syncope had ventricular ycardia on ambulatory ECG moni-
Hypertrophic cardiomyopathy in childhood is associated
with a poor prognosis (1-6) ; approximately 50% of patients
in whom the diagnosis is established between the ages of l
and 14 years die suddenly within 9 years of diagnosis
(1,3,5,6). This high mortality rate observed in previous
studies occurred despite selection criteria that excluded
children with a family history of multiple sudden deaths .
In the past few years, several potential mechanisms for
cardiac arrest and syncope have been identified in patients
with hypertrophic cardiomyopathy (7-13). In adults, ventric-
ular arrhythmias are very prevalent and are believed to be
the most important cause of sudden cardiac arrest and
syncope; about half of the adult patients with previous
cardiac arrest or syncope have nonsustained ventricular
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HYPERTROPHIC CARDIOYOPATHY
toting. However, all 15 patients, had inducible ischemia by
thallium scintigraaphy compared with only 3 (37%) of I patients
with no such history (p < 0 .01) . lot contrast, ventricular tachy-
cardla induction was uncommon in all of the young patients (27
In those with cardiac arrest or syncope, 0 in the others) . During
therapy for ischemia with verapamil alone or in combination with
beta-adrenergic blocking agents, only 4 of the 15 patients with
cardiac arrest or syncope had further episodes . In three of the
four patients, these events were temporally related to discontinu-
ation of verapamil. Among eight patients who had a repent
exercise thallium study while receiving anti-ischemic therapy,
seven ( %) had improved regional thallium uptake, of whom
three had normal thallium studies,
Conclusions . These data suggest that in young patients with
hypertrophic cardiomyo thy, sudden cardiac arrest or syncope
is frequently related to ischemia rather than to a primary arrhyth .
mogenic ventricular substrate .
(J Am Coll Cordial 1993,22 :796--804)
tachycardia during ambulatory electrocardiographic (ECG)
monitoring, and more than two thirds of cardiac arrest
survivors have an inducible, sustained ventricular tachycar-
dia by programmed electrical stimulation (11,12) . However,
in young patients with hypertrophic cardiomyopathy who
have sustained a previous cardiac arrest, ventricular ar-
rhythmias are infrequent on ambulatory ECG monitoring
(3-5';, suggesting that the primary mechanism for sudden
death in young patients differs from that in adults .
Angina and myocardial ischemia are prominent features
of hypertrophic cardiomyopathy in adult patients, and evi-
dence suggests that ischemia can be present even in young
asymptomatic patients (12-18) . It is therefore possible that
ischemia may contribute to the development of syncope and
sudden cardiac arrest in such patients . The objectives of this
study, therefore, were to determine I) the frequency of
myocardial ischemia as a potential mechanism of cardiac
arrest and syncope in young patients with hypertrophic
cardiomyopathy who experienced such complications, and
2) whether anti-ischemic medications, such as beta-
adrenergic or calcium-channel blocking agents, can prevent
0735-10971931$6.00
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future episodes of cardiac arrest and syncope in these
patients .
Methods
Patient selection. Twenty-three young patients with hy-
pertrophic cardiomyopathy, aged 6 to 23 years, with previ-
ous cardiac arrest (n := 8), syncope (n = 7) or a family history
of sudden cardiac death (n = 8) were evaluated to determine
the prevalence of spontaneous ambulatory ventricular tachy-
cardia (24- to 72-h ECG monitoring), exercise-induced myo-
cardial ischemia (thallium scintigraphy) and inducibility of
ventricular tachycardia (electrophysiologic studies) . All pa-
tietus underwent a history and physical examination, chest
X-ray study, ECG, echocardiography, 24- to 72-h ECG
monitoring, exercise thallium tomography, radionuclide an-
giography and electrophysiologic studies . The diagnosis of
hypertrophic cardiomyopathy was based on the echocardio-
graphic demonstration of a nondilated, hypertrophied left
ventricle (wall thickness ~ 14 mm) in the absence of another
cardiac or systemic cause for the left ventricular hypertro-
phy (19). Significant left ventricular outflow tract obstruction
was defined as a left ventricular outflow tract gradient
?30 mm Hg under basal conditions or ?50 mm Hg after
provocative maneuvers (Valsalva maneuver, amyl nitrite
inhalation or isoproterenol infusion) . All studies were per-
formed after discontinuation of all cardiac medications .
There were 14 male and 9 female patients .
All patients consented to undergo exercise thallium to-
mography and electrophysiologic studies . The National
Heart, Lung, and Blood Institutional Committee on Human
Research approved these studies for patients with hypertro-
phic cardiomyopathy under protocol 84-H-232 . The whole
body radiation dose resulting from thallium scintigraphy is
l .1 rem, with a cardiac dose of 1 .6 rem .
Exercise thallium singlo-photon emission computed tomo-
graphic imaging. Patients underwent exercise thallium-201
single-photon emission computed tomography (SPECT), as
previously described (20) . After an overnight fast, exercise
thallium scintigraphy was performed according to a stan-
dardized multistage, symptom-limited (i .e ., chest pain,
shortness of breath, fatigue) treadmill exercise test with
continuous monitoring of symptoms, 17-.CG, heart rate and
blood pressure . At peak exercise, 1 .5 to 2 mCi of thallium-
201 was administered intravenously, and the patient contin-
ued exercise for an additional 45 to 60 s . After termination of
exercise, thallium images were obtained using a wide field of
view rotating gamma camera equipped with a low energy,
medium resolution, high sensitivity, parallel hole collimator
(Apex 415, APC-3, Elscint Co .) centered on the 68-keV
photopeak with a 20% window . The camera was rotated over
a 180° arc in an elliptic orbit about the patient's thorax from
40° right anterior oblique to 40° left posterior oblique at 6°
increments for 30 s each . Images were acquired 3 to 4 h after
exercise and after the administration of 0 .5 to I mCi of
thallium-201 reinjection at rest (20) . From the raw scinti-
graphic data, horizontal long-axis, vertical long-axis and
short-axiss tomograms were reconstructed, and four consec-
utive representative slices of each view were selected for
interpretation
. The reconstructed stress and reinjection im-
ages were then analyzed qualitatively .
egional thallium analysis . The distribution of thallium
uptake was analyzed qualitatively in the three standard
orthogonal tomographic imaging planes as follows : the sep-
tal, apical and lateral regions in the horizontal long-axis
(transaxial) view; the anterior, apical and inferior regions in
the vertical long-axis (sagittal) view, and the anterior, septal,
inferior and lateral regions in the short-axis (oblique) view .
The stress and reinjection images were normalized to the
region with the maximal myocardial activity in the stress
images . Four consecutive representative slices of each view
were dispioyed simultaneously for interpretation . The im-
ages were graded by two experienced observers, in a blinded
manner, on a 4-point scale from 3 (+++) = markedly
reduced/absent activity to 2 (++) = moderately reduced, I
(+) = mildly reduced and 0 H = normal. The grade
assigned to a given region was the lowest regional score from
all tomographic slices and views . A counts-based quantita-
tive analysis based on absolute thallium activity was not
performed because the marked regional heterogeneity of
wall thickness in hypertrophic cardiomyopathy would ac-
centuate partial volume effects in a region to region compar-
ison within one tomographic plane (21) .
Electrophysiologic studies . All patients underwent elec-
trophysiologic studies involving the assessment of sinus
node function, atrioventricular node and His-Purkinje con-
duction, atria( and ventricular refractoriness and pro-
grammed ventricular stimulation, as previously described
(11). After an overnight fast and sedation with I to 4 mg of
intravenous midazolam, three multiple electrode catheters
(5F or 6F, Bard or Mansfield) were introduced percutane . -
ously into a femoral vein and positioned under fluoroscopic
guidance in the high right atrium, across the tricuspid valve
in the region of the His bundle and at the right ventricular
apex. A femoral artery was also cannulated for continuous
recording of the systemic arterial pressure. After pro-
grammed atrial stimulation, the high right atrial catheter was
repo°~itioned in the right ventricular outflow tract for pro-
grammed ventricular stimulation. The programmed ventric-
ular stimulation protocol involved a stepwise increase in
"aggressiveness" as follows: 1) insertion of one, two and
three premature stimuli during sinus rhythm at the right
ventricular apex ; 2) introduction of one and two premature
stimuli after three paced ventricular drive cycle lengths of
600, 500 and 400 ms, first at the right ventricular apex and
then at the right ventricular outflow tract ; 3) introduction of
three premature stimuli after the three paced drive cycle
lengths at the right ventricular apex and right ventricular
outflow tract ; and 4) insertion of one, two, and three
premature stimuli after the three drive cycle lengths at a left
ventricular site
. The end point of the stimulation protocol
was refractoriness or induction of a sustained ventricular
797
798
DILSIZIAN ET AL.
	
JACC Vol . 22, No . 3
MYOCARDIAL ISCHEMIA IN YOUNG PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY September 1993 :796-804
Table 1 .
Characteristics of Young Patients With Hypertrophic Cardiomyopathy
arrhythmia (>30-s duration or requiring rapid termination
due to hemodynamic compromise) .
Patient management and follow-up. All patients with car-
diac arrest who had a suitable body habitus were provided
with an implantable defibrillator. All patients with symptoms
of impaired consciousness and evidence of exercise-induced
myocardial ischemia were also treated with verapamil or
beta-blockers, or both . Patients with syncope in whom
programmed electrical stimulation induced a sustained ven-
tricular tachycardia were initially treated with antiarrhyth-
mic drugs. If pharmacotherapy did not prevent subsequent
induction of ventricular tachycardia, the patient was pro-
vided with an implantable defibrillator . Asymptomatic pa-
tients were treated only if programmed stimulation with
two or fewer premature stimuli resulted in induction of
a sustained ventricular tachycardia. Follow-up consisted of
3- to 6-month clinic visits and telephone interrogation of
patients, their relatives and cardiologists .
Statistical analysis. Data are presented as mean value t
SD. Differences between myocardial ischemia by thallium
scintigraphy and inducible ventricular tachycardia by elec-
trophysiologic studies in patients with cardiac arrest or
syncope and those with a family history of sudden cardiac
death were performed by chi-square analysis . Dfferences
between patients with and without impaired consciousness
with respect to age, and results of treadmill exercise, 24-
to
72-h ECG monitoring, echocardiography, left ventricular
end-diastolic pressure measurements, rest and provokable
left ventricular outflow tract gradients and ejection fraction
were analyzed by either two-tailed unpaired t test
4)r chi-
square analysis .
Values presented are mean value ± SD or number . ECG = electrocardiographic
; HR = heart rate ; IVS
interventricular septal thickness ; LVEDP = left ventricular end-diastolic pressure
; LVEF = left ventricular ejection
fraction ; LVOT
- left ventricular outflow tract ; PW = posterior wall ; RPP = rate-pressure product ; SAM = systolic
anterior motion of the mitral valve ; VT = ventricular tachycardia.
Results
The data acquired in the 23 patients were analyzed
accordhig to their symptomatic presentation . One group
comprised patients with a previous history of cardiac arrest
or syncope; the other group comprised those who had only a
family history of cardiac arrest (Table 1) . The patients with
a previous history of cardiac arrest or syncope achieved a
lower peak heart rate and rate-pressure product . Six of the
15 patients with a history of impaired consciousness had
exercise-induced angina compared with only I of 8 patients
with no such history. Only 3 of 15 patients with a history of
impaired consciousness had ventricular tachycardia during
24- to 72-h ambulatory ECG monitoring . On M-mode echo-
cardiography, the interventricular septal thickness, septal/
posterior free wall ratio and the incidence of systolic anterior
motion of the mitral valve were not different between the
two groups. The two groups also did not differ with respect
to left ventricular end-diastolic pressure, left ventricular
ejection fraction and the frequency of significant left ventric-
ular outflow tract gradients at rest and during provocation .
Prevalence of myocardial ischemia. The prevalence of
exercise-induced myocardial ischemia by thallium SPECT
and of inducible ventricular I lachycardia by electrophysio-
logic study in the 23 young patients with hypertrophic
cardiomyopathy is presented in Table 2 . All 15 patients with
either cardiac arrest or syncope developed myocardial isch-
emia on exercise thallium studies compared with 3 (37%) of
8 patients with a family history of sudden cardiac death (p <
0.01) .
Details of all exercise treadmill and thallium scintigraphic
Cardiac Arrest
or Syncope
(n = 15)
Family History
of Cardiac Arrest
(n
= 8)
p Value
Age (yr)
15 ± 5 19±4 NS
Treadmill exercise
Duration (min)
8 ± 2 10 . 4 NS
Peak HR (beats/min)
155 ± 27 181 ± 15 < 0.01
RPP (1010 3 ± 5
29±5 <0.001
Angina
Os 1/8 NS
24-72-h ECG monitor (VT) 315 0/8 NS
Echocardiography
IVS (mm) 24 ± 10 NS23±9
IVSIPW (mm) 2 .2 0 .8 2 .1 ± 0 .7 NS
SAM
5115 418
NS
Catheterization
LVEDP (mm Hg) 14±7 NS18 . 7
LVOT obstruction
Rest (130 mm Hg) 2/8 NS2/ 15
Provocation QM mm Hg) N15 5/8 NS
Radionuclide angiography, LVEF 68 ± 13 79 ± 10 NS
JACC Vol . 22, No . 3
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Table 2 . Prevalence of ti rocardial lqchemia by Thallium
Scintigraphy and Inducible Wentricular Tachycardia by
Electrophysiologic Study
Cardiac arrest or syncope
	
15115 0013%)*
4115
(27%)
Family history of cardiac arrest 318 (37%)* 018 (0%)
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TI-201 SPELT, EP Study .
Ischemin Innducible VT
*P < 0 .01 . EP = clectrophysiologic
; SPECT = single-photon emission
computed tomography ; T1 = thallium ; VT = ventricular tachycardia .
data are presented in Table 3 . Ischemic ST segment depres-
sion during exercise was present in 9 of 15 patients with
either cardiac arrest or syncope, and all 9 patients had
associated ischemia by thallium scintigraphy . However,
thallium scintigraphy identified six additional patients with
myocardial ischemia who had no ECG evidence of ischernia
or tracings that were uttinterprelable for ischemia because of
left bundle branch block or paced rhythm . Exercise-induced
ventricular arrhythmias did not occur in any patient during
their supervised treadmill test . Thallium abnormalities oc-
curred most commonly in the aateroapical and sepia] regions
of the left ventricle ; 15 of the 18 patients with exercise-
induced myocardial ischemia had thallium abnormalities
in more than one region . Eleven patients had apparent
exercise-induced left ventricular cavity dilation and three
patients had increased lung uptake of thallium during exer-
cise .
Prevalence of inducible ventricular tachycardia. Only 4
(27%) of 15 patients with either cardiac arrest or syncope and
none of 8 patients with a family %istory of cardiac arrest had
a sustained ventricular tachycardia induced during pro-
grammed electrical stimulation . Ali four patients had sus-
tained polymorphic ventricular tachycardia that was induc-
ible at a right ventricular site . None of the patients had any
other electrophysiologic abnormalities that would have
played a role in their sudden cardiac arrest or syncope .
Long-term follow-up and therapeutic response, All pa-
tients who had previous cardiac arrest or syncope and who
also had exercise-induced thallium perfusion defects re-
ceived anti-ischemic therapy with verapamil, alone or in com-
bination with a beta-blocker. Eight patients had follow-up
thallium studies during anti-ischemic therapy. Regional thal-
lium defects essened in 18 of 21 regions, associated with a
reduction in defect severity score from 1 .9 ± 0.6 to 0.6 ± 0.8
(p < 0.001). Seven (88%) of the eight patients had improved
regional thallium uptake on medical therapy, of whom three
had completely normal thallium studies . All three patients with
exercise-induced left ventricular cavity dilation before therapy
had reduced cavity size on medical therapy . An example of a
patient with improvement in exercise-induced myocardial isch-
emia and apparent cavity dilation during verapamil therapy is
shown in Figure 1 .
Of the nine patients with ischemic ST segment depression
on baseline exercise study, six had follow-up exercise tread-
mill studies while they were receiving anti-ischemic therapy .
iwhemic ST segment changes lessened with medical therapy
in five (83%) of the six patients, of whom four had no ECG
evidence for ischemia . These ECG improvements from
before to after medical therapy occurred at comparable
exercise duration (8 .5 ± 2.0 and 9 .8 ± 2.0, p = NS), heart
rate (157 ± 23 and 162 ± 16, p = NS) and rate-pressure
product (18 X
103
± 5 and 20 X 10' ± 6, p = NS) . Three of
the nine patients also had improvement in symptomatic
exercise end points .
During a mean follow-up period of 23 ± 6 months, 4 of the
15 patients with symptoms of impaired consciousness had
further events, only I of whom had beet found on electro-
physiologic study to have inducible ventricular tachycardia .
The first patient was a 9-year old girl with documented
myocardial ischemia who had had multiple recurrent epi-
sodes of cardiac arrest and syncope before verapamil ther-
apy, She had an episode of presyncope about 6 h after failing
to take her verapamil dose at home .
The second patient, I I years old, with a previous cardiac
arrest and evidence of exercise-induced myocardial ischemia
in the absence of electrophysiologic abnormalities, had two
episodes of syncope within 12 h of in-hospital discontinua-
tion of verapamil and beta-blocker therapy . The syncopal
episodes were precipitated by sinus tachycardia and were
associated with marked ST segment depression, hypoten-
sion and polymorphic ventricular tachycardia that was ter-
minated by defibrillator discharges (Fig . 2). An episode of
presyncope in the same patient was associates with tachy .,
cardia and ST segment depression and nonsustained poly .
morphic ventricular tachycardia (Fig . 2) .
The third patient, 19 years old, with a previous cardiac
arrest and findings of exercise-induced myocardial ischemia
(in the absence of electrophysiologic abnormalities), had an
episode of syncope accompanied by a discharge from an
implantable defibrillator while standing, about 30 min after
vigorous exercise . At the time of the event she was receiving
verapamil (240 mg/day) ; however, after the verapamil dose
was increased to 360 mg/day, she has had no further epi-
sodes .
The fourth patient, an 1,1,'-year old woman with a previous
cardiac arrest who had both exercise-induced myocardial
ischerckia and inducible, s : -rained polymorphic ventricular
tachycardia at electrophysiologic study, was provided with
an implantable defibrillator and treated medically with a
beta-blocker and verapamil . She was otherwise free from
cardiac symptoms . When the medications were discontin-
ued, she had a syncopal episode on exercise testing ; this was
associated with induction of a sustained polymorphic ven-
tricular tachycardia that was terminated by a single dis-
charge by the defibrillator . After resuming her medication,
she had no further episodes during a 2-year follow-up .
In contrast to the patients
with impaired consciousness,
only one of the eight patients with no such history had an
event on long-term follow-up. This patient was a 14-year old
boy with a normal ambulatory ECG recording and no
inducible ventricular tachycardia who developed septal and
A
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ansenmer"-_E kohem~n on exercise thallium scintigraphy .
Because he was asymptomatic, he was kept untreated ;
however, I year later he experienced a syncopal episode
while playing basketball .
Discussion
"The results of the present investigation, involving a
selected group of young patients with hypertrophic cardio-
myopathy, demonstrate that evidence of inducible ischemia
by thallium scintigraphy is frequently observed in patients
with a history of either sudden cardiac arrest or syncope but
is relatively uncommon in young asymptomatic patients,
even among those with a family history of sudden cardiac
death. In contrast, inducible ventricular tachycardia by
electrophysiologic studies is uncommon, occurring in only
27% of patients with cardiac arrest or syncope in our series
and in none of the patients with only a family history of
sudden cardiac arrest . This is an unexpected result because
ventricular arrhythmia is commonly considered to be the
most frequent factor precipitating sudden cardiac arrest in
patients with hypertrophic cardiomyopathy (7-13) . How-
ever, this conclusion is based predominantly on adults with
sudden cardiac death and syncope, and the mechanism
responsible for these events in young patients has not been
established .
Myocardial ischemia, as assessed by reversible exercise-
induced regional thallium abnormalities, is a prominent
feature of hypertrophic cardiomyopathy in adults (14-16)
and has been associated with potentially lethal arrhythmias
(17). That thallium abnormalities observed in hypertrophic
cardiomyopathy represent myocardial ischemia is supported
by the concordance of these abnormalities and abnormal
lactate metabolism during rapid atria] pacing (18), improve-
ment of thallium abnormalities after surgical relief of left
ventricular outflow obstruction (22) and the excellent con-
cordance with another perfusion agent, technetium-99m
sestamibi, whose uptake is independent of the active
sodium-potassium adenosine triphosphatase transport sys-
tem (23) . However, the prevalence and importance of myo-
cardial ischemia in young patients with bypertrophic cardio-
myopathy, and their relation to ventricular arrhythmias,
have not been established .
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figure 1 . Thallium tomograms at baseline and after verapamil
therapy in a patient with a previous cardiac arrest . Three consecu-
tive 3-pixel thick short-axis tomograms from apex to base are
displayed for stress (top) and reinjection (bottom) . before verapamil
therapy (left panel), there are extensive exercise-induced thallium
abnormalities in the anterior, septal and inferior regions that nor-
malize on reinjection images 3 to 4 h later, consistent with extensive
reversible myocardial ischemia . After verapamil therapy (right
paaet), exercise-induced thallium abnormalities are lessened .
Mechanisms of myocardial ischemia in byptrilrophic car-
diognyopathy. Possible mechanisms for the development of
myocardial ischemia in such patients may relate to inade-
quate myocardial blood flow and increased myocardial oxy-
gen demand during exercise . Myocardial ischemiaa in pa-
tients with hypertrophic cardiomyopathy, in the absence of
epicardial coronary artery stenosis, may be due to intramu-
ral small vessel abnormalities, abnormal myocellular archi-
tecture or massive hypertrophy. Impaired left ventricular
relaxation and elevated end-diastolic filling pressures during
diastole may result in compressive effects on the coronary
microcirculation and restrict coronary artery blood flow (24).
In addition, coronary vasodilator response may be limited by
abnormalities of the intramural small coronary arteries that
are characteristic of hypertrophic cardiomyopathy (25,26) .
Myocardial ischemia could be further aggravated by the
increases in oxygen demand associated with myocardial
hypertrophy (27,28) and, in some patients, due to elevated
systolic pressures as a result of outflow tract obstruction .
Such recurrent myocardial ischemia may cause myocardial
injury and scarring, which potentially can reduce the thresh-
old for ventriculaiv arrhythmias .
In adults, only ventricular tachycardia on ambulatory
ECG monitoring (8,9)
and a family history of sudden death
(29) had been associated with an increased risk of sudden
cardiac arrest. More recently, ventricular tachycardia in-
duced by programmed electrical stimulation has been shown
to be an even more powerful predictor of sudden cardiac
arrest (11) . In young patients, ambulatory ECG monitoring is
of uncertain importance in identifying those patients at risk
for sudden death . For example, only 3 of the 23 patients in
the current study had arrhythmias on 24- to 72-h ambulatory
ECG monitoring, even though 8 had a history of cardiac
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arrest and another 7 had a history of syncope . Similar
findings of extremely low prevalence of ventricular tachy-
cardia on ambulatory ECG monitoring in young patients
have been previously reported by McKenna et al . (8) . In
addition, and as mentioned earlier, only 4 of the 15 patients
with proved cardiac arrest or syncope had ventricular tachy-
cardia induced by programmed electrical stimulation .
Identification of inducible myocardial ischemia by thal-
lium scintigraphy in 37%, of patients who had no symptoms
of impaired consciousness but had a family history of sudden
cardiac arrest may identify the subgroup of young, asymp-
tomatic patients with hypertrophic cardiomyopathy who are
at risk for a future cardiac event
. One of the asymptomatic
patients in our series who had a positive thallium test had a
subsequent syncopal episode several months later
. In addi-
tion, repeated episodes of ischemia in young patients may
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Figure 2. Electrocardiograms
(ECGs) from an I I -year old boy Who
was referred because of a history of
recurrent cardiac arrests . A, The
baseline ECG shows minor ST-T
wave abnormalities commonly seen
in patients with hypertrophic cardio-
myopathy . S, During treadmill exer-
cise, 12-mm ST segment depression
developed in the inferolateral leads .
C, Serial telemetry ECG recordings
from the same patient at rest reveal
the development of sinus tachycar-
dia first associated with significant
ST segment depression, followed by
a nonsustained polymorphic ventric-
ular tachycardia . D, An episode of
presyncope was associated with sus-
tained polymorphic ventricular
tachycardia that was terminated by
an electric shock from an implant-
able cardiac defibrillator . E, Another
episode of marked ST -,egment de-
pression that was associated with
hypotension (brachial artery pres-
sure 60/40 nun Hg) and light-headed-
ness was treated successfully with
intravenous (iv) infusion of I mg of
propranolol (Inderal) .
result in small areas of myocardial fibrosis . In those who
survive to adulthood, such fibrotic areas may serve as foci
for reentrant pathways responsible for the ventricular ar-
rhythmias commonly encountered in adults with hypertro-
phic cardiomyopathy . Thus, although definitive data are
lacking, it would appear reasonable to treat young, asymp-
tomatic patients with verapamil if they have evidence of
inducible ischemia and hypotension by stress thallium scin-
tigraphy . This proposal is based on the evidence in this study
and others (16) that verapamil reduces the prevalence and
severity of ischemia during exercise .
Treatment of patients with hypertrophic cardiomyopathy .
Medical treatment of hypertrophic cardiomyopathy has con-
sisted primarily of administration of beta-blockers and cal-
cium channel blockers. The mechanism responsible for the
salutary effects of beta-blocker therapy may relate to the
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inhibition of sympathetic stimulation of the heart and dimi-
nution of myocardial oxygen requirements by reducing heart
rate, left ventricular contractility, outflow tract obstruction
and myocardial wall stress during exercise (30) . The first
evidence suggesting that beta-blockers may have a protec-
tive effect against premature sudden death in young patients
with hypertrophic cardiomyopathy was provided by Fidler
et al . (2) in 1978 . In their retrospective analysis of children
with hypertrophic cardiomyopathy, 7 (54%) of 13 children
(with a mean outflow gradient of 41 mm Hg) who received no
therapy died within a mean of 5 .2 years . In contrast, none of
the seven children who received propranolol therapy (mean
outflow gradient 42 mm Hg) died .
Over the past decade, calcium channel blockers such as
verapamil have also been shown to be effective therapeutic
agents in hypertrophic cardiomyopathy (16,31-34) . The
mechanism responsible for the beneficial effects of verapamil
may be partly due to diminished myocardial oxygen con-
sumption and left ventricular contractility, similar to that
observed with beta-blockers ; however, unlike beta-blockers,
verapamil has also been shown to improve indexes of left
ventricular relaxation and rapid diastolic filling (32-34) asso-
ciated with enhanced exercise performance and reduced
symptoms (34) . Verapamil also has the capacity to dilate
small arteries, an action that may have salutary effects in
patients with hypertrophic cardiomyopathy, who have been
shown to have both anatomic and functional abnormalities of
the small coronary arteries (24,26) .
In the present study, 11 (73%) of 15 young patients who
presented with cardiac arrest or syncope had no further
events during treatment with verapamil alone or in combi-
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Figure 3. Schematic flow
diagram for the management of young
patients with hypertrophic cardiomyopathy .
nation with beta-blockers during a mean follow-up period of
-2 years . In three of the four patients with events, the event
occurred shortly after verapamil was discontinued . Further-
more, 88% of patients who had a repeat exercise thallium
study while receiving anti-ischemic therapy had either re-
duced or no myocardial ischemia . Thus, therapy with either
a beta-blocker or verapamil may diminish the likelihood of
inducible ischemia and thereby of recurrent syncope or
cardiac arrest in young patients with hypertrophic cardiomy-
opathy . However, a survivor of cardiac arrest who had
myocardial ischemia on exercise thallium study, and who did
not have spontaneous or inducible ventricular arrhythmias,
had an episode of exercise-induced syncope associated with
discharge by an implantable defibrillator during treatment
with verapamil (240 mg/day) . Hence, it would appear pru-
dc.nt to provide all children with cardiac arrest, who are of
suitable body habitus, with an implantable defibrillator in
addition to anti-ischemic medical therapy . A proposed man-
agement scheme for young patients with hypertrophic car-
diomyopathy presenting with cardiac arrest, syncope or
strong family history of sudden cardiac death is outlined in
Figure 3 .
Summary. The results of our study in a small group of
young patients with hypertrophic cardiomyopathy referred
for risk stratification suggest that cardiac arrest or syncope is
frequently related to myocardial ischemia rather than to a
primary arrhythmogenic left ventricular substrate . Further-
more, anti-ischemic medications, such as beta-blockers and
JACC Vol. 22, No. 3
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verapamil, appear to lessen symptoms and reduce the like-
lihood of future episodes of sudden cardiac arrest in such
young patients .
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